跳至主要内容
临床试验/NCT02403427
NCT02403427Unknown不适用

The Voice Decision Support Expert System in Basal-bolus Insulin Therapy of Diabetes Patients.

Instytut Diabetologii Sp. z o.o.2 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2015年3月最近更新:
适应症

试验速览

阶段
不适用
入组人数
42
试验地点
2
主要终点
postprandial glucose

研究概览

简要总结

The purpose of this study to conduct the preliminary investigation on the efficacy and safety in terms of postprandial glucose value and the rates of hypoglycaemia when expert VoiceDiab system supports patient's decision on prandial insulin programming in insulin pump therapy.

详细描述

In children with type 1 diabetes glucose deterioration occurred every day and night leading into low satisfaction with treatment. Unstable glycemic profile resulting in high glycemic variability depends on the adjustment of insulin dosing to the current needs of the organism. The calculation of prandial insulin dosing is a complex process which involves such factors as preprandial blood glucose level, the amount of food taken, the glycemic index of carbohydrates, the insulin/carbohydrate exchange ratio, the active insulin level following the previous bolus. Currently, in patients treated with continuous subcutaneous insulin infusion (CSII) insulin pumps are equipped with bolus calculators which help to calculate prandial insulin dosing and thus contribute to improve post-prandial blood glucose levels.

The aim of the study was to determine whether the patient's support expert VoiceDiab system have stabilised diurnal glucose profile in children with type 1 diabetes treated with insulin pumps.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
3 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed type 1 diabetes at least 12 month prior screening visit
  • Current treatment with basal-bolus regime and insulin pump for at least 12 weeks prior screening visit.
  • HbAc < 11%
  • Ability and willingness to adhere to the protocol including self-management and dealing with mobile device.

排除标准

  • Multiply daily injection modality,
  • Treatment with regular insulin,
  • Use of any anti-diabetic agent,

结局指标

主要结局

postprandial glucose

时间窗: 96 houres

postprandial glucose with respect the hyperglycaemia above 180 mg/dl

次要结局

  • AUC(240 mintues after each study's meal)
  • PPGE- postprandial glucose excursion(96 houres)
  • hypoglycemia(96 houres)
  • LBGI(96 houres)
  • Glucose variability parameters(96 houres)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ewa Pankowska

associate professor

Instytut Diabetologii Sp. z o.o.

研究点 (2)

Loading locations...

相似试验

The Expert System VoiceDiab in Children With Diabetes | 临床试验